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esponsibility of Xi'aAbstract Ultra-performance liquid chromatography coupled with quadrupole time-of-ﬂight tandem
mass spectrometry (UPLC–Q-TOF/MS) was developed to identify the absorbed parent components and
metabolites in rat bile, plasma and urine after oral administration of Radix Paeoniae Alba extract (RPAE).
A total of 65 compounds were detected in rat bile, plasma and urine samples, including 11 parent
compounds and 54 metabolites. The results indicated that glucuronidation, hydroxylation and methylation
were the major metabolic pathways of the components of RPAE. Furthermore, the results of this work
demonstrated that UPLC–Q-TOF/MS combined with MetaboLynx™ software and mass defect ﬁltering
(MDF) could provide unique high throughput capabilities for drug metabolism study, with excellent MS
mass accuracy and enhanced MSE data acquisition. With the MSE technique, both precursor and fragment
mass spectra can be simultaneously acquired by alternating between high and low collision energy during
a single chromatographic run.
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Radix Paeoniae Alba, the roots of plant Paeonia lactiﬂora Pall
(Family Ranunculaceae), referred as Baishao in China, is a
commonly used medicinal herb in traditional Chinese medicine
(TCM). Modern phytochemical and pharmacological studies have
shown that the major bioactive components of Radix Paeoniae arevier B.V. All rights reserved.
Metabolites identiﬁcation of Radix Paeoniae Alba with UPLC–Q-TOF/MS 15monoterpene glycosides, galloyl glucoses and phenolic compounds
[1–3]. It displays a range of pharmacological activities such as anti-
inﬂammatory [4], anti-oxidant [5], antiallergic [6], anti-thrombosis [7],
immunoregulating [8], cognition-enhancing [9], antihyperglycemic
effects [10] and kidney protection effect in diabetic rats [11].
The components of RPAE have been identiﬁed thoroughly in vitro
[12–15]. Li et al. [16] have identiﬁed 40 components in RPAE with
UPLC–Q-TOF/MS. As the analytical method in Li's [16] research
was well developed to identify the components in RPAE. In our
study, the same analytical method with minor changes including the
high energy in MSE mode and MS/MS mode, was used to analyze the
in-vitro and in-vivo samples. The pharmacokinetic parameters of
RPAE have been investigated [17], but the studies on metabolism of
RPAE are limited. There have been some reports on the metabolism
studies of the components of RPAE, such as paeoniﬂorin, one main
component of RPAE. Paeoniﬂorin possesses wide pharmacological
effects in the nervous system. It has been used in the treatment of
epilepsy, cerebral ischemia and neurodegenerative disorders such as
Alzheimer's disease. And it also exhibits anticoagulant, neuromuscular
blocking, cognition-enhancing and immunoregulating and antihyper-
glycemic effects. In Su et al.'s [18] study, metabolite hydroxyl-
paeoniﬂorin was identiﬁed in rat plasma after oral administration
of Shaofu Zhuyu decoction active extract. Previous studies had repor-
ted low bioavailability of orally administered paeoniﬂorin in rats
(approximately 3–4%) [19,20], metabolism of paeoniﬂorin is an
important mechanism that is responsible for poor bioavailability of
paeoniﬂorin. Administered paeoniﬂorin was extensively metabolized
into paeoniﬂorgenin, paeonimetabolins I and II [21–23]. Most of the
components in RPAE possess the same parent structure and just differ
in substituents such as thionyl, hydroxy and methyl. Besides, theFig. 1 Chemical structures of 14content of paeoniﬂorin is larger compared to other monoterpene
glycosides in RPAE and the reference of paeoniﬂorin could be
purchased. Therefore, paeoniﬂorin is chosen as the representative to
study the metabolism behaviors of monoterpene glycosides in RPAE.
In our study, pure paeoniﬂorin was administered to rats to characterize
the metabolic pathways of monoterpene glucosides. The results
elucidate the analysis of the various metabolites of other monoterpene
glucosides from RPAE.
In order to get more metabolism information of RPAE from the
complex biological matrics, it is necessary to develop effective and
reliable analytical methods for detection. Recently, UPLC–ESI-Q-
TOF/MS system with automated MSE data analysis software
(Metabolynx™) has been proved to be a powerful and reliable
analytical approach for in vivo metabolite identiﬁcation studies
[24–26]. With this efﬁcient tool, we studied thoroughly the
absorbed components and metabolites in rat bile, plasma and
urine after oral administration of RPAE. These absorbed compo-
nents and metabolites might be the bioactive substances of RPAE
in vivo and should be screened on pharmacological models to pave
a way for research on the effect related to the mechanism of action.
2. Materials and methods
2.1. Chemicals and regents
The standards of albiﬂorin, paeoniﬂorin and catechin (purity
498%, see their structures in Fig. 1) were purchased from the
National Institute for Drug Control of China (Beijing, China).
Acetonitrile (Merk, Germany), methanol (Merk, Germany) and
formic acid (Fisher Scientiﬁc, Farilawn, NJ, USA) were of HPLCparent compounds of RPAE.
Z.-W. Chen et al.16grade, and other chemicals and regents were of analytical grade.
De-ionized water was prepared by a Milli-Q puriﬁcation system
(Millipore, Bedford, MA, USA). Waters Oasis HLB Solid-phase
extraction cartridge (30 mg/mL) was purchased from Waters Corp.
2.2. Preparation of RPAE
The dried powder of Radix Paeoniae Alba (Bozhou, Anhui, China)
extract was supplied by Tianjin Tasly Pharmaceutical Co. Ltd
(Tianjin, China). The preparation process was as follows:
the pulverized samples of Radix Paeoniae Alba (50.0 g) was
immersed in 400 mL water and extracted in a reﬂux water bath for
2 times, 2 h for each time. Proper amount of 95% ethanol was added
into the extracts to adjust the concentration of ethanol to 70%. The
solution was kept at 4 1C for 12 h then ﬁltered. Cake was dried and
went through 80 mesh sieve to yield RPAE. The RPAE was dissolved
in methanol and ﬁltered through a 0.22 μmmembrane before analysis.
2.3. Animal experiments
Animal studies were conducted according to the protocols
approved by the Animal Ethics Committee of Tasly Group.
Animal experiments adhered to the National Institutes of Health
Guide for the Care and Use of Laboratory Animals. Twenty four
male Wistar rats (weighing 200720 g) were purchased from
Beijing Vital River Laboratories (Beijing, China) and kept under
controlled environmental conditions (temperature 2272 1C;
humidity 50710%) with free access to the standard laboratory
food and water. The animals were divided into four groups with 6
rats in each group. One group was used for collection of bile after
oral administration of paeoniﬂorin at the dose of 400 mg/kg. The
other three groups were used for collection of bile, urine and
plasma samples after oral administration of RPAE at the dose of
3 g/kg RPAE (namely, 18.75 g/kg for crude drug) respectively.
The dose of RPAE was picked according to the publications on the
pharmacokinetic studies of RPAE.
The rats were fasted for 12 h with free access to water prior to
the experiments. Blank bile, plasma and urine samples were
collected before administration with drugs. The rats were anesthe-
tized with 20% urethane (m/m) at the dose of 0.7 mL/100 g, then
ﬁxed on wooden plates. An abdominal incision was made and bile
duct was cannulated with PE tubing for collection of bile samples
continually for 12 h after administration. The blood samples (0.5 mL
each time) were collected from ophthalmic veins of the rats by sterile
capillary tube at 0.5, 1, 2, 4 and 6 h after administration. The blood
samples were centrifuged at 3500 rpm for 10 min immediately to get
plasma. Urine samples were collected continually for 12 h after
administration. Meanwhile the rats were kept free access to water.
All the samples were stored at 20 1C.2.4. Preparation of urine, plasma and bile samples
A solid-phase extraction (SPE) method was used for plasma and urine
pretreatment. Before applying to sample, a SPE cartridge was treated
with 1 mL of water, 1 mL of methanol and 1 mL of water
successively. An aliquot of 0.5 mL plasma and urine sample was
vortexed, loaded, and allowed to ﬂow through the SPE cartridge with
pressure. The SPE cartridge was then washed with 1 mL of water and
2 mL of methanol successively. The methanol eluate was collected and
evaporated under a stream of N2 at room temperature. The driedsample was dissolved in 200 μL methanol for analysis. The bile
samples were mixed with acetonitrile (1:1, v/v) and centrifuged at
12,000 g for 10 min. The supernatant was used for analysis.
2.5. UPLC–Q-TOF/MS analytical system
Chromatographic experiments were performed on Waters Acquity
UPLC system (Waters Corp., Milford, MA, USA) equipped with a
2998 photodiode array detector (PDA) together with a quaternary
pump, an auto-sample injector, an on-line degasser and an automatic
thermostatic column oven. The in-vitro and in-vivo samples were
separated on a Waters Acquity UPLC HSS T3 column (2.1 mm
100 mm; 1.8 μm) with the column temperature maintained at 35 1C.
A linear gradient elution of solvent acetonitrile (A) and 0.1% formic
acid aqueous solution (B, v/v) was applied with the following
program: 2–5% A (0–2 min), 5–12% A (2–4 min), 12–20% A (4–
8 min), 20–30% A (8–9 min), 30–50% A (9–10 min), and 50–100%
A (10–12 min) at 0.3 mL/min. UV spectra were recorded from 190 to
400 nm. The temperature of autosampler tray was maintained at 4 1C
through the analysis process. The injection volume was 2 μL for
in-vitro samples and 10 μL for in-vivo samples.
The MS instrument consisted of a Waters Synapt G2 Q-TOF/
MS (Waters Corp., Milford, MA, USA) equipped with an electro-
spray ionization (ESI) source. Both positive and negative ion
modes were tested, and it was found that the sensitivities for most
components in RPAE were higher in the negative ion mode.
Ultrahigh purity argon (Ar) was used as the collision gas and high
purity nitrogen (N2) as the nebulizing gas. The nebulization gas was
set to 650 L/h desolvation temperature at 300 1C, while the cone gas
and the source temperature were set to 50 L/h and 90 1C,
respectively. The capillary voltage and sample cone voltage were
set to 2700 V and 35 V, respectively. The Q-TOF Premier acquisition
rate was set to 0.3 s, with a 0.05 s inter-scan delay. Argon was
employed as the collision gas at a pressure of 7.1 103 Pa. The
energies for collision-induced dissociation (CID) were set at 5 eV in
low energy and 30–50 eV ramp voltage in high energy in MSE mode
respectively for fragmentation information. For some peaks, the MS/
MS mode at 30–50 eV ramp voltage was further employed to get the
fragmentation information. All MS data were acquired using the
LockSpray to ensure mass accuracy and reproducibility. The
[MH] ion of leucine-enkephalin at m/z 554.2615 was used as
the lock mass in negative electrospray ionization mode. The
concentration of leucine-enkephalin was 2 ng/μL and the infusion
ﬂow rate was 5 μL/min. Sodium formate solution at the concentration
of 0.5 mM was used to create the calibration ﬁle. The data were
acquired in centroid mode with the mass ranged from 100 to
1000 Da. The Elemental Composition function of the software
Metabolynx™ was used to predict the formulas of chemicals.
Screening and identiﬁcation of the metabolites of PRAE was assisted
by the software Metabolynx™ (Waters Corp., Milford, MA, USA).
2.6. Software to calculate n-octanol/water partition coefﬁcient
(log P)
Software chembiodraw ultra 11.0 (Cambridgesofts, Cambridge, MA)
based on theoretical calculations was used to predict n-octanol/water
partition coefﬁcient (log P). The prediction of log P is based on 222
atomic contributions calculated from 1868 molecules by least squares
analysis. This method allows a calculation of log P with a standard
deviation of 0.43 log P units and can handle molecules containing
hydrogen, oxygen, nitrogen, sulfur, halogens and phosphorus atoms.
Table 1 The compounds identiﬁed from bile, plasma and urine after oral administration of the RPAE by UPLC–ESI-Q-TOF/MS.
No. RT
(min)
m/z [M–H]
Found
PPM Metabolite name Formula
[M–H]
Fragment ions Parent
drug
Identiﬁcation Bile Plasma Urine
M1 1.02 802.2350 1.1 +GSH+O C33H45N3O18S 784,766,511,306,272,254,210,143,128 PAE +  
M2 1.03 453.0736 7.2 Hy–Glc+Glu C16H22O13S 179,277, OPS +  
M3 1.04 262.9858 1.5 +CH2+SO3 C8H8O8S 183,168,150,124,203,96 GaA 3-Hydroxy-5-methoxy-4-(sulfooxy)benzoic acid +  
M4 1.05 671.1819 0.7 +O+Glu C29H36O18 495,465,447,333,137 PAE + + 
M5 1.06 575.1063 1.4 +O+SO3 C23H28O15S PAE + + 
M6 3.09 262.9839 8.7 +CH2+SO3 C8H8O8S 183,168,150,124,203,96 GaA 3-Hydroxy-4-methoxy-5-(sulfooxy)benzoic acid +  
P1 3.15 359.1335 1.9 – C16H23O9 179,197 – 1-O-β-D-Glucopyranosyl-paeonisuffrone  + +
M7 3.51 453.0682 4.7 Hy–Glc+Glu C16H22O13S 179,277, OPS +  
M8 3.64 359.0607 2.1 +CH2+Glu C14H16O11 183,168,125,227,314,175,193 GaA +  
M9 3.74 345.0434 7 +Glu C13H14O11 169,125, GaA +  
M10 3.91 373.0779 2.1 +2CH2+Glu C15H18O11 197,182,175,167,178,354,305 GaA +  
M11 3.97 671.1837 2 +O+Glu C29H36O18 495,465,375,345,281,195,177,152,137 IsP +  
M12 4.05 802.2358 2.1 +GSH+O C33H45N3O18S 784,766,511,306,272,254,210,143,128 PAE +  
M13 4.16 233.0131 4.7 +2CH2–
CO2+SO3
C8H10O6S 109,124,153 GaA 2,6-Dimethoxyphenyl hydrogen sulfate +  
M14 4.18 495.1513 2.1 +O C23H28O12 137,165,177,195,281, 283, 327,345, PAE + + 
P2 4.2 559.1122 0 – C23H28O14S 137,161,247,259,421 – Oxypaeoniﬂorin sulfonate + + +
M15 4.25 671.1831 1.1 +O+Glu C29H36O18 495,465,447,333,137 PAE + + 
M16 4.31 802.2358 2.1 +GSH+O C33H45N3O18S 784,766,511,306,272,254,210,143,128 PAE +  
M17 4.37 701.1921 1.2 +Glu C30H38O19 363,453,525 ME +  
M18 4.4 262.9850 4.5 +CH2+SO3 C8H8O8S 183,168,150,124,203,96 GaA 4-Hydroxy-3-methoxy-5-(sulfooxy)benzoic acid +  +
M19 4.43 717.1884 0.8 +O+Glu C30H38O20 225,255,312,327,461,651,669,687,493,543 ME +  
M20 4.5 373.0770 0.3 +2CH2+Glu C15H18O11 197,182,175,167,153 GaA +  
M21 4.61 701.1934 0.7 +Glu C30H38O19 239,327,363,495,525 ME +  
P3 4.68 589.1221 1.1 – C24H30O15S 167,259,331,375,421,535,574 – Isomaltopaeoniﬂorin sulfonate + + +
M22 4.74 277.0017 0.5 +2CH2+SO3 C9H10O8S 107,124,167,182,197 GaA 3,5-Dimethoxy-4-(sulfooxy)benzoic acid +  
M23 4.88 621.1166 6.5 +O+SO3 C24H30O17S 225,327,346,361,445,511,541 ME +  
M24 4.91 495.1498 1 +O C23H28O12 137,165,177,195,281, 283, 327,345, PAE + + 
M25 5 655.1887 1.9 +Glu C29H36O17 319,481 IsP +  
M26 5.01 605.1142 5.7 +O C24H30O16S 183,241,525,544 MES 6-Hydroxy mudanpioside E sulfonate +  
M27 5.01 701.1924 0.8 +Glu C30H38O19 285,525 ME +  
M28 5.02 575.1044 4.7 +O+SO3 C23H28O15S 137,495,465 PAE + + 
M29 5.04 717.1868 1.5 +O+Glu C30H38O20 284,511,543,574 ME + + 
P4 5.16 705.1695 0.8 – C29H38O18S 121,259,421,543,583 – Mudanpioside E sulfonate + + +
M30 5.28 575.1054 2.9 +O+SO3 C23H28O15S 137,495,465 PAE + + 
M31 5.3 605.1144 5.4 +O C24H30O16S 183,495,525 MES 2-Hydroxy mudanpioside E sulfonate +  
P5 5.32 543.117 0.5 – C23H28O13S 121,213,259,375,421 – Paeoniﬂorin sulfonate + + +
M32 5.32 479.1189 0.2 +CH2+Glu C22H24O12 202,217,244,259,285,303 Cat + + 
M33 5.38 717.1868 1.5 +O+Glu C30H38O20 ME + + 
M34 5.43 605.1143 5.5 +O C24H30O16S 183,277,403,425,439,525, MES 5-Hydroxy mudanpioside E sulfonate +  
M35 5.54 479.1190 0 +CH2+Glu C22H24O12 219,244,259,285,303 Cat + + 
M36 5.55 383.0439 0.5 +CH2+SO3 C16H16O9S 303,285,259,244,216,202,164,137 Cat + + 
M37 5.55 621.1121 0.8 +O+SO3 C24H30O17S 210,255,285,327,346,361,445,493,407,541 ME +  
M38 5.63 449.1465 3.8 –CH2–O C22H26O10 165,327,273,309,291,386,430,447 IsP +  
M
etabolites
identiﬁcation
of
R
adix
P
aeoniae
A
lba
w
ith
U
P
L
C
–Q
-T
O
F
/M
S
17
Table 1 (continued )
No. RT
(min)
m/z [M–H]
Found
PPM Metabolite name Formula
[M–H]
Fragment ions Parent
drug
Identiﬁcation Bile Plasma Urine
M39 5.65 373.0757 3.8 +2CH2+Glu C15H18O11 197,182,193,167,175,250,255 GaA +  
M40 5.66 479.1203 2.8 +CH2 C22H24O12 219,244,259,285,303 Cat + + 
M41 5.67 701.1915 2 +Glu C30H38O19 363,525 ME +  
P6 5.79 495.1488 3 – C23H28O12 137,165,289, 407,421,465 – Oxypaeoniﬂorin or oxypaeoniﬂorin isomer +  
M42 6.13 277.0023 1.7 +2CH2+SO3 C9H10O8S 107,124,167,182,197 GaA 3,4-Dimethoxy-5-(sulfooxy)benzoic acid +  
M43 6.34 495.1483 4 +O C23H28O12 137,165, 283, 327,345, PAE +  +
M44 6.37 621.1127 0.2 +O+SO3 C24H30O17S 345,427,445,523,541, ME + 
M45 6.47 479.1191 0.3 +CH2+Glu C22H24O12 219,244,259,285,303 Cat +  +
M46 6.6 621.1140 2.3 +O+SO3 C24H30O17S 511,523,541 ME +  
M47 6.72 233.0103 7.3 +2CH2–
CO2+SO3
C8H10O6S 109,124,153 GaA 2,3-Dimethoxyphenyl hydrogen sulfate +  
M48 6.86 383.0431 1.6 +CH2+SO3 C16H16O9S 303,285,259,244,216,202,164,137 Cat +  
M49 6.96 655.1865 1.4 +Glu C29H36O17 319,481 IsP +  
M50 7.14 449.1446 0.4 –CH2–O C22H26O10 165,327,273,309,291,386,430,447 IsP + + 
M51 7.29 577.1219 1.5 +H2+O C23H30O15S 272,382,400,497 OPS +  
P7 7.33 479.1562 1.7 – C23H28O11 121,195,283, 327,357,375 – Albiﬂorin + + +
M52 7.49 383.0431 1.6 +CH2+SO3 C16H16O9S 303,285,259,244,216,202,164,137 Cat + + 
M53 7.7 655.1886 1.8 +Glu C29H36O17 319,481 IsP +  
M54 7.79 449.1444 0.9 –CH2–O C22H26O10 165,327,273,309,291,386,430,447 IsP + + +
P8 7.81 479.1543 2.2 – C23H28O11 121,165,283, 327,345,431,449 – Paeoniﬂorin + + +
P9 8.25 495.1502 0.2 – C23H28O12 137,169,325,443 – Ortho-oxypaeoniﬂorin +  
P10 9.46 631.1661 0.3 – C30H32O15 169,313,399, – Galloylpaeoniﬂorin or galloylalbiﬂroin or their
isomers
+  
P11 10.24 647.1447 1.9 – C30H32O14S 121,169,213,259,313,479,525,631 – Benzoylpaeoniﬂorin sulfonate + + +
1. Cat: catechin; GaA: gallic acid; IsP: isomer of paeoniﬂorin; ME: Mudanpioside E; MES: Mudanpioside E sulfonate; OPS: Oxypaeoniﬂorin sulfonate; PAE: paeoniﬂorin.
2. –CO2: Decarboxylation; +SO3: sulfate conjugation; +Glu: glucuronide conjugation; –CH2: demethylation; +CH2: methylation; –O: loss of oxygen; +O: hydroxylation; +GSH: glutathione conjugation;
Hy: hydrolisis; –Glc: deglucose; +H2: reduction.
3. P: the parent components in RPAE; M: metabolites; PPM: parts per million.
4. +: detected, : not detected.
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the standard deviation is 0.83 log P units.3. Results and discussion
3.1. Identiﬁcation of components from RPAE in vitro
RPAE was dissolved in methanol and ﬁltered through a 0.22 μm
membrane ﬁlter unit, and 2 μL was injected for analysis. Com-
pounds albiﬂorin, paeoniﬂorin and catechin in RSE were unam-
biguously identiﬁed by the comparison of retention time (tR), UV
spectrum, and fragments information as shown in Table 1 with
their standards. The rest peaks in the chromatograms of RPAE
were identiﬁed by comparing their accurate masses, retention time,
UV spectra and fragmentation information with those reported in
literature [12–16]. Chemical structures of 14 parent compounds of
RPAE are shown in Fig. 1.
3.2. Identiﬁcation of parent components in bile, plasma and
urine after oral administration of RPAE
By comparing the accurate masses, retention time and fragmenta-
tion information of peaks appearing in the chromatograms of bile,
plasma and urine with those previously identiﬁed in RPAE
in vitro, 11 peaks were detected as prototype components of
RPAE. Their extracted ion chromatograms are shown in Fig. 2.
3.3. Characterization of metabolites of single standard
RPAE contains multiple compounds with signiﬁcant varieties in
structural types, physiochemical properties, and relative amounts.Fig. 2 Extracted ion chromatograms in negative mode of 11 parent compo
are 1-O-β-D-glucopyranosyl-paeonisuffrone, oxypaeoniﬂorin sulfonate, iso
sulfonate, oxypaeoniﬂorin or oxypaeoniﬂorin isomer, albiﬂorin, paeoniﬂorin
isomers, benzoylpaeoniﬂorin sulfonate, respectively.When they were administered by oral route, lots of compounds
may get into circulation and then be converted into a mixture of
metabolites of unknown origin. Meanwhile, chemicals in herbal
medicine usually present in the form of a series of analogs with the
same skeleton but different functionalities and their metabolites
may undergo similar fragmentation and produce some of the same
ions. Understanding the metabolic pathway of certain parent drugs
will greatly facilitate metabolite identiﬁcation of their analogs.
Therefore, in our study paeoniﬂorin was chosen as the representa-
tive to study the metabolic pathways of monoterpene glycosides.
The fragmentation pathways of paeoniﬂorin (shown in Fig. 3)
were investigated thoroughly which will throw light upon the
identiﬁcation of the metabolites. In addition, as only one single
compound was fed to rats, the metabolic proﬁles were easy to be
elucidated. The result indicated that hydroxylation, glucuronida-
tion, glutathione (GSH) conjugation and sulfation predominated
the metabolism of paeoniﬂorin.3.4. n-octanol/water partition coefﬁcient (log P)
It was common that several metabolites were assigned as isomers in
biological matrices. To elucidate the exact structures of these isomers,
such as the positions of conjugation or hydroxylation, were challen-
ging due to little differences present in their MS spectra. Log P, an
important parameter in the process of designing new drugs, provides
the direct information on hydrophobicity that describes the tendency
of distribution of a drug from aqueous phase into biological
membranes [27]. Software chembiodraw ultra 11.0 was used to
predict Log P. Generally, for compounds with log Po4, the calcu-
lated log P values are almost the same as the experimental measure-
ments. The larger log P is the less retention time it would have on the
reverse phase chromatography [28,29].unds (P1–P11) detected in bile (B), plasma (P) and urine (U). P1–P11
maltopaeoniﬂorin sulfonate, mudanpioside E sulfonate, paeoniﬂorin
, ortho-oxypaeoniﬂorin, galloylpaeoniﬂorin or galloylalbiﬂroin or their
Fig. 3 Proposed fragmentation pathways of paeoniﬂorin.
Fig. 4 Proposed metabolic pathways of paeoniﬂorin-related metabolites.
Z.-W. Chen et al.203.5. Identiﬁcation of metabolites from bile, urine, plasma after
oral administration of RPAE
Besides the 11 prototype compounds, 54 peaks were tentatively
presumed to be metabolites of RPAE, and could be generally divided
into three groups: monoterpene glycosides-related, catechin-related
and gallic acid-related metabolites.
3.5.1. Identiﬁcation of monoterpene glycoside-related
metabolites
3.5.1.1. Identiﬁcation of paeoniﬂorin-related metabolites. A
total of 11 compounds detected in rat bile, plasma and urine were
tentatively assigned as metabolites originating from paeoniﬂorin.
From the results shown in Table 1, we can see that paeoniﬂorin
underwent hydroxylation before undergoing phase II metabolic
reaction. They all shared the same fragment ion at m/z 137
corresponding to the hydroxylated benzene ring.
M14, M24 and M43 shared a series of characteristic ions
at m/z 165, 283, 327 and 345 with paeoniﬂorin. In addition,
according to the accurate molecular mass, M14, M24 and M43
were 16 Da higher than paeoniﬂorin. Thus, M14, M24 and M43
were assigned as hydroxylation products of paeoniﬂorin. The
shorter retention time of M14, M24 and M43 than that of
paeoniﬂorin (tR¼7.81 min) on the RP-UPLC column also
supported the tentative identiﬁcation as oxidation metabolites
of paeoniﬂorin.M5, M28 and M30 shared a series of characteristic ions of
hydroxylated paeoniﬂorin at m/z 495, 465 and 137. In addition, the
molecular weight of M5, M28 and M30 was 80 Da (SO3) higher
than that of hydroxylated paeoniﬂorin, indicating that they were
sulfate conjugates of hydroxylated paeoniﬂorin. M4 and M15
shared a series of characteristic ions of hydroxylated paeoniﬂorin
at m/z 447 and 333. The molecular weight of M4 and M15 was
176 Da higher than that of hydroxylated paeoniﬂorin, indicating that
they were glucuronide conjugates of hydroxylated paeoniﬂorin.
For metabolites M1, M12 and M16, a series of characteristic ions
of glutathione at m/z 306, 272, 254, 210, 143 and 128 were
observed. Their molecular weight was 307 Da higher than hydro-
xylated paeoniﬂorin, so they were tentatively identiﬁed as glu-
tathione conjugates of hydroxylated paeoniﬂorin. The proposed
metabolic pathways of paeoniﬂorin are shown in Fig. 4 and the
extracted ion chromatograms of paeoniﬂorin-related metabolites
are shown in Fig. 5.
3.5.1.2. Identiﬁcation of mudanpioside E-related metabolites.
Metabolites M23, M37, M44 and M46 gave [MH] ions at
m/z 621.1166, 621.1121, 621.1127 and 621.1140 respectively,
which were calculated as C30H38O19 by the Elemental Composi-
tion function of software Metabolynx™. Their different retention
times suggested they were isomers. They shared a series of
characteristic ions at m/z 345, 511, 523 and 541 with mudanpio-
side E. The [MH] ion at m/z 621 yielded a product ion at
m/z 541 with a loss of 80 Da (SO3), suggesting that they were
Fig. 5 Extracted ion chromatograms of paeoniﬂorin-related metabolites from rat bile in negative mode.
Fig. 6 Proposed metabolic pathways of mudanpioside E-related
metabolites.
Metabolites identiﬁcation of Radix Paeoniae Alba with UPLC–Q-TOF/MS 21sulfate conjugates. In addition, the ion at m/z 541 is 16 Da higher
than that of mudanpioside E, indicating that M23, M37, M44 and
M46 were sulfate conjugates of hydroxylated mudanpioside E.
According to the accurate mass, the molecular weight of M17,
M21, M27 and M41 was 176 Da higher than that of mudanpioside
E. In addition, their fragments ions were similar to that of
mudanpioside E, suggesting that they were glucuronide conjugates
of mudanpioside E. While the molecular weight of M19, M29 and
M33 was 16 Da higher than that of M17, suggesting that they were
glucuronide conjugates of hydroxylated mudanpioside E. The
proposed metabolic pathways of mudanpioside E are shown in
Fig. 6 and the extracted ion chromatograms of mudanpioside E-
related metabolites are shown in Fig. 7.
3.5.1.3. Identiﬁcation of mudanpioside E sulfate-related metabo-
lites. M26, M31 and M34 yielded an ion at m/z 183, indicating
that the benzene ring was hydroxylated. In addition, their [MH]
ion at m/z 605 gave a product ion at m/z 525 with a loss of 80 Da
(SO3) and their molecular weight was 16 Da higher than that of
mudanpioside E sulfate, so they were tentatively identiﬁed as
hydroxylated mudanpioside E sulfate. There were three places in
the benzene ring of mudanpioside E sulfate that could be
hydroxylated. According to the fact that one with a larger log P
value would have less retention time on the reverse phase
chromatography, M26 (tR¼5.01 min, log P¼3.648), M31
(tR¼5.3 min, log P¼–3.898) and M34 (tR¼5.43 min, log P¼
–3.928) were tentatively identiﬁed as 6-hydroxy mudanpioside E
sulfonate, 2-hydroxy mudanpioside E sulfonate and 5-hydroxy
mudanpioside E sulfonate, respectively. The extracted ion chro-
matograms of mudanpioside E-related metabolites are shown in
Fig. 7.
3.5.1.4. Identiﬁcation of oxypaeoniﬂorin sulfonate-related meta-
bolites. Metabolites M2 and M7 gave a [MH] ion at m/z
453.0682 and 453.0736 respectively, calculated as C16H22O13S.
In addition, M2 and M7 gave an ion at m/z 277 with a loss of
176 Da, suggesting that they were glucuronide conjugates. Based
on the information above, M2 and M7 were tentatively identiﬁed
as glucuronide conjugates after oxypaeoniﬂorin sulfonate under-
going hydrolysis and deglucose reactions. M51 gave a [MH]ion at m/z 577.1219 (C23H30O15S), which yielded a product ion at
m/z 497 with a loss of 80 Da (SO3), corresponding to the
characteristic loss of oxypaeoniﬂorin sulfonate. Thus M51 was
tentatively identiﬁed as the reduction and hydroxylation product of
oxypaeoniﬂorin sulfonate. The extracted ion chromatograms of
oxypaeoniﬂorin sulfonate-related metabolites are shown in Fig. 8.
3.5.1.5. Identiﬁcation of isomer of paeoniﬂorin-related metabo-
lites. Three isomers of paeoniﬂorin (m/z¼479.1543, C23H28O11)
were identiﬁed in vitro as albiﬂorin, isopaeoniﬂorin and albiﬂorin
R1 according to their fragmentation information. M25, M49 and
M53 produced fragment ions at m/z 319 and 481, corresponding to
loss of 176 Da and 162 Da. So they were tentatively identiﬁed as
glucuronide conjugates of isomer of paeoniﬂorin. The molecular
weight of M11 was 16 Da (O) higher than that of M25 and also
shared the loss of 176 Da. Thus M11 was tentatively identiﬁed as
glucuronide conjugate of hydroxylated isomer of paeoniﬂorin.
M38, M50 and M54 gave [MH] ions at m/z 449.1465,
Fig. 7 Extracted ion chromatograms of mudanpioside E-related and mudanpioside E sulfate-related metabolites from rat bile in negative mode.
Fig. 8 Extracted ion chromatograms of oxypaeoniﬂorin sulfate and isomer of paeoniﬂorin-related metabolites from rat bile in negative mode.
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C22H26O10. They shared the same characteristic ions at m/z 165
and 327 with paeoniﬂorin. Moreover, compared with the mole-
cular weight of paeoniﬂorin, they were 30 Da less, which was
tentatively assigned to CH2 (14 Da) and O (16 Da). Thus M38,
M50 and M54 were tentatively identiﬁed as demethylation and
loss of oxygen products of isomer of paeoniﬂorin. The extracted
ion chromatograms of isomer of paeoniﬂorin-related metabolites
are shown in Fig. 8.
3.5.2. Identiﬁcation of catechin-related metabolites
M36, M48 and M52 gave [MH] ions at m/z 383, which
produced a product ion at m/z 303 with a loss of 80 Da (SO3),
indicating that they were sulfate conjugates. The presence of ions
at m/z 259 and 244 suggested that there was a methyl group(15 Da). Thus M36, M48 and M52 were tentatively identiﬁed as
methylation and sulfation conjugates of catechin. M32, M35, M40
and M45 gave a [MH] ion at m/z 479, which produced a
product ion at m/z 303 with a loss of 176 Da, indicating that they
were glucuronide conjugates. The presence of product ions at m/z
259 and 244 suggested that there was a methyl group (15 Da).
Thus M32, M35, M40 and M45 were tentatively identiﬁed as
methylation and glucuronide conjugates of catechin. The extracted
ion chromatograms of catechin-related metabolites are shown in
Fig. 9.
3.5.3. Identiﬁcation of gallic acid-related metabolites
M22 and M42 gave a [MH] ion at m/z 277, which gave a
product ion at m/z 197 with a loss of 80 Da (SO3), suggesting that
they were sulfate conjugates. The presence of product ions at
Fig. 9 Extracted ion chromatograms of catechin-related metabolites from rat bile in negative mode.
Fig. 10 Proposed metabolic pathways of gallic acid-related metabolites.
Metabolites identiﬁcation of Radix Paeoniae Alba with UPLC–Q-TOF/MS 23m/z 197,182 and 167 indicated that there were two methyl groups.
So M22 and M42 were assigned as sulfation and double methyla-
tion conjugates of gallic acid. According to the fact that one with
larger log P value would have less retention time on the reverse
phase chromatography, M22 (tR¼4.73 min, log P¼–0.189) and
M42 (tR¼6.13 min, log P¼–0.539) were tentatively identiﬁed as
3,5-dimethoxy-4-(sulfooxy)benzoic acid and 3,4-dimethoxy-5-
(sulfooxy)benzoic acid, respectively.
As for M13 and M47, the [MH] ion at m/z 233.0131
(C8H10O6S) was 44 Da less than that of M22, suggesting that they
were the decarboxylation products of M22. Thus M13 and M47
were assigned as decarboxylation products after sulfation and
double methylation of gallic acid. M13 (tR¼4.16 min, log P¼–
0.004) and M47 (tR¼6.72 min, log P¼–0.354) were tentatively
identiﬁed as 2,6-dimethoxyphenyl hydrogen sulfate and 2,3-
dimethoxyphenyl hydrogen sulfate, respectively. M3, M6 and
M18 gave a [MH] ion at m/z 263, which yielded product ions at
m/z 183 and 168, with a loss of 80 Da (SO3) and 15 Da (CH3).
Thus M3, M6 and M18 were assigned as methylation and sulfate
conjugates of gallic acid.
M9 gave a [MH] ion at 345.0434 (C13H14O11), which led to
a product ion at m/z 169 with the loss of 176 Da, suggesting that it
was glucuronide conjugate of gallic acid. The molecular weight of
M8 was 14 Da (CH2) higher than that of M9, indicating that M8
was methylated M9. So M8 was tentatively identiﬁed as methyla-
tion and glucuronide conjugate of gallic acid.M10, M20 and M39 yielded [MH] ions at m/z 373, which
could lead to fragment ion at m/z 197 with a loss of 176 Da,
suggesting that they were glucuronide conjugates. Moreover, the
presence of product ions at m/z 197, 182 and 167 implied that
there were two methyl groups. Thus M10, M20 and M39 were
tentatively identiﬁed as glucuronide and double methylation
conjugates of gallic acid. The proposed metabolic pathways of
gallic acid are shown in Fig. 10 and the extracted ion chromato-
grams of gallic acid-related metabolites are shown in Fig. 11.
3.6. Discussions
Isomers are the groups of compounds with the same exact masses
and elemental compositions. In most cases, these compounds are
similar in structure and polarity and also have similar cleavage
pathways, which is difﬁcult for analysts to deal with [30]. As for
LC–MS method, there are three ways to distinguish them,
including the retention time, the differences of fragment ions
and UV spectra. For some isomers, they could be distinguished by
analyzing their retention time and n-octanol/water partition coefﬁ-
cient. The larger the n-octanol/water partition coefﬁcient is, the
smaller the retention time is on the reverse phase chromatography.
The software chembiodraw ultra 11.0 could be used to calculate
the n-octanol/water partition coefﬁcient. The maximum absorption
wavelength in UV spectra will change according to the different
positions of these moieties. So the UV spectra can help pinpoint
Fig. 11 Extracted ion chromatograms of gallic acid-related metabolites from rat bile in negative mode.
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of the metabolites are very close that make it impossible to
separate them completely on chromatography, so the UV spectra
could not be used to distinguish them. For most of the isomers, the
difference of fragmentation information could hardly be found as
the structures seem so alike. Therefore, judging from the factors
illustrated above, some metabolites in our study cannot be given
exact structures. Further studies such as 1H and 13C NMR are
needed to clarify the exact structures of these isomers.4. Conclusion
In our study, a total of 54 metabolites were detected and the
metabolic pathways were proposed. This is the ﬁrst study to
establish the metabolic proﬁle of RPAE, which is helpful in
revealing the bioactive components of RPAE. Moreover, it was
demonstrated that the high-speed and sensitive UPLC–Q-TOF/MS
analytical system combined with the software Metabolynx™ was a
useful tool to identify metabolites in herbal medicine.
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